This Web Site is committed to the memory of Janis Morrow.
Labs
Esophageal Strictures The esophagus is a relatively simple tubular structure connecting the throat to the stomach. The major functions of the stomach are to transport ingested food from the oropharynx to the stomach and to prevent regurgitation of food and gastric contents from the stomach back up into the esophagus. At the same time it allows air to be vented out of the stomach thus relieving abdominal bloating. On occasion, a narrowed area will occur in the esophagus resulting in an interruption in the normal swallowing mechanism. This may result in dysphagia or difficulty swallowing. Passage of food or liquid may be impaired through the esophagus with a sensation of a fullness in the chest, pressure-like sensation, shortness of breath and inability to swallow food, liquids or saliva. In many cases this is transient in nature and may only last a short time but on occasion may be prolonged requiring emergent intervention. This narrowing of the esophagus can be caused by many different conditions. The most common of which is a benign stricture. This is the result of peptic esophagitis or gastroesophageal reflux disease and can occur at any age but is more common after the age of 40. The fundamental abnormality is excessive acid reflux from the stomach up into the esophagus resulting in an inflammatory reaction in the lower esophagus that leads to scarring after repeated injury and healing. Eventually, scar tissue is formed and a benign stricture develops which is in the form of a concentric ring that narrows the opening of the esophagus. A hiatal hernia is often present in association with the reflux. This concentric lower esophageal ring sometimes called a Schatzki's ring often occurs at the junction between the esophagus and the stomach and sometimes can be present for years. When diagnosed, it can be easily treated by passage of a dilator through the area to break open the scar tissue and relieve the narrowed area. Other causes of benign esophageal strictures may be congenital in nature such as a membranous diaphragm or web that can occur anywhere in the esophagus but frequently occurs in the upper portion. This is also treated by dilation either through an endoscope or by passage of Bougie dilator. Other conditions leading to benign strictures include corrosive injury to the esophagus from ingestion of a toxic substance (i.e. cleaning solutions, radiation injury to the esophagus, post surgical strictures, or achalasia, which is a gradual thickening of the musculature at the lower end of the esophagus). Other conditions could cause dysphagia (difficulty swallowing), even though no stricture is present. In that case, various neurological conditions, vascular abnormalities, diverticulum, spastic motility disorders, or skeletal muscle disorders like muscular dystrophy and myasthenia gravis are possibilities. In addition to the above, a malignant condition may develop causing a stricture or narrowing of the esophagus. There are about 11,000 new cases of cancer of the esophagus diagnosed yearly and is correlated with smoking or excessive alcohol ingestion, particularly in young adulthood. It is more frequent in men than women and also more frequent in blacks than whites. Esophageal cancer can develop anywhere along the esophagus but is more frequent in the lower portion. A condition called Barrett's esophagus may occur in the lower esophagus due to chronic gastroesophageal reflux disease. This condition is diagnosed by esophageal biopsy and is reflected by a change in the cellular structure of the lower esophagus. Patients who have this condition are at higher risk for developing adenocarcinoma of the lower esophagus and must be screened by performing upper endoscopy on a regular basis. Treatment of a benign esophageal stricture consists of esophageal dilation. This is most commonly done at the time of an upper endoscopy. The upper endoscopy is where a video endoscope is placed through the mouth into the esophagus while the patient is under an IV sedation. The esophagus is then examined and if a benign stricture is present it can be dilated in various ways. A balloon dilator passed through the endoscope is often inflated within the confines of the stricture, thus opening the area and relieving the patient's symptoms. Other types of dilators may also be passed although not through the endoscope. These are called Mallony or savory dilators in increasing sizes in order to break open the stricture. In either case, the patients are sedated and should not feel anything during the procedure. The risks of a dilation include potential bleeding, infection or a tear. If a tear is deep enough, on rare occasion, it might require surgical repair. Treatment of a malignant stricture of the esophagus is available but can often be disappointing. If the malignancy is determined to be small and localized without any spread beyond the esophagus then a surgical repair is often opted for and may, on rare occasion cure the cancer. If the tumor is not curable, then often, palliative treatments are employed which include chemotherapy, radiation therapy, esophageal dilation, laser treatments, injections, tumor probes or placement of an esophageal stent (wire mesh tube) to keep the esophagus open. In any situation the patient must work closely with his or her physician to decide what is the best approach for that individual since it varies from patient to patient. ERCP (Endoscopic Retrograde Cholangiopancreatography)
Preparation |
||||||||||||||||||
| Sclerotherapy for esophageal varices (also called endoscopic sclerotherapy) Author/s: Lori De Milto DefinitionSclerotherapy for esophageal varices (also called endoscopic sclerotherapy) is a treatment for esophageal bleeding that involves the use of an endoscope and the injection of a sclerosing solution into veins. PurposeIn most hospitals, sclerotherapy for esophageal varices is the treatment of choice to stop esophageal bleeding during acute episodes, and to prevent further incidences of bleeding. Emergency sclerotherapy is often followed by preventive treatments to eradicate distended esophageal veins. PrecautionsSclerotherapy for esophageal varices cannot be performed on an uncooperative patient, since movement during the procedure could cause the vein to tear or the esophagus to perforate and bleed. It should not be performed on a patient with a perforated gastrointestinal tract. DescriptionEsophageal varices are enlarged or swollen veins on the lining of the esophagus which are prone to bleeding. They are life-threatening, and can be fatal in up to 50% of patients. They usually appear in patients with severe liver disease. Sclerotherapy for esophageal varices involves injecting a strong and irritating solution (a sclerosant) into the veins and/or the area beside the distended vein. The sclerosant injected into the vein causes blood clots to form and stops the bleeding. The sclerosant injected into the area beside the distended vein stops the bleeding by thickening and swelling the vein to compress the blood vessel. Most physicians inject the sclerosant directly into the vein, although injections into the vein and the surrounding area are both effective. Once bleeding has been stopped, the treatment can be used to significantly reduce or destroy the varices. Sclerotherapy for esophageal varices is performed by a physician in a hospital, with the patient awake but sedated. Hyoscine butylbromide (Buscopan) may be administered to freeze the esophagus, making injection of the sclerosant easier. During the procedure, an endoscope is passed through the patient's mouth to the esophagus to view the inside. The branches of the blood vessels at or just above where the stomach and esophagus come together, the usual site of variceal bleeding, are located. After the bleeding vein is identified, a long, flexible sclerotherapy needle is passed through the endoscope. When the tip of the needle's sheath is in place, the needle is advanced, and the sclerosant is injected into the vein or the surrounding area. The most commonly used sclerosants are ethanolamine and sodium tetradecyl sulfate. The needle is withdrawn. The procedure is repeated as many times as necessary to eradicate all distended veins. Sclerotherapy for esophageal varices controls acute bleeding in about 90% of patients, but it may have to be repeated within the first 48 hours to achieve this success rate. During the initial hospitalization, sclerotherapy is usually performed two or three times. Preventive treatments are scheduled every few weeks or so, depending on the patient's risk level and healing rate. Several studies have shown that the risk of recurrent bleeding is much lower in patients treated with sclerotherapy: 30-50%, as opposed to 70-80% for patients not treated with sclerotherapy. PreparationBefore sclerotherapy for esophageal varices, the patient's vital signs and other pertinent data are recorded, an intravenous line is inserted to administer fluid or blood, and a sedative is prescribed. AftercareAfter sclerotherapy for esophageal varices, the patient will be observed for signs of blood loss, lung complications, fever, a perforated esophagus, or other complications. Vital signs are monitored, and the intravenous line maintained. Pain medication is usually prescribed. After leaving the hospital, the patient follows a diet prescribed by the physician, and, if appropriate, can take mild pain relievers. RisksSclerotherapy for esophageal varices has a 20-40% incidence of complications, and a one to two percent mortality rate. Complications can arise from the sclerosant or the endoscopic procedure. Minor complications, which are uncomfortable but do not require active treatment or prolonged hospitalization, include transient chest pain, difficulty swallowing, and fever, which usually go away after a few days. Some people have allergic reactions to the solution. Infection occurs in up to 50% of cases. In 2-10% of patients, the esophagus tightens, but this can usually be treated with dilatation. More serious complications may occur in 10-15% of patients treated with sclerotherapy. These include perforation or bleeding of the esophagus and lung problems, such as aspiration pneumonia. Long-term sclerotherapy can damage the esophagus, and increase the patient's risk of developing cancer. Patients with advanced liver disease complicated by bleeding are very poor risks for this procedure. The surgery, premedications, and anesthesia may be sufficient to tip the patient into protein intoxication and hepatic coma. The blood in the bowels acts like a high protein meal; therefore, protein intoxication may be induced. Key Terms
Varicose Veins in Esophagus Varicose veins in the esophagus (known as varices) are similar to the varicose veins often seen in the legs. In short, they are twisted, dilated veins that develop because of increased pressure in the venous system. In the esophagus, varices often stem from high pressures in the portal venous system, which are veins that normally drain into the liver from the intestinal tract. Increased pressure in the portal venous system is most often the result of cirrhosis in the liver. As the portal venous pressure goes up, the blood must be diverted to other veins, and is then channeled most commonly to varices in the esophagus. Varices can also occur in the stomach and in the rectum, although less commonly. The problem that is often encountered with varices is their propensity to bleed. Bleeding occurs because of increased tension in the wall of the varices, leading to rupture. Bleeding varices are a dreaded complication of cirrhosis, with the death rate approaching 30 to 50 percent. Patients with bleeding varices usually vomit blood and/or pass black stools. By the time they get medical help, they often have lost significant amounts of blood and have low blood pressure requiring resuscitation. The therapy for bleeding varices involves an upper endoscopy to pinpoint the site of bleeding, followed by injection of a solution to destroy the varices or, as you mentioned, variceal banding. Banding involves using an endoscope to place a small, rubber band around a varicose vein. This effectively cuts off the blood flow, and, over the next several days, the rubber band and the tissue within it will spontaneously fall off. The esophagus lining at the site will slowly heal. Banding is very effective in eradicating varices, and it often is repeated at set intervals over weeks until all the varices have been obliterated. The most common side effect after banding is difficulty swallowing. Some patients feel that food is becoming stuck in their esophagus. The reason for this is that the bands (as many as 12 may be placed at one session) take up space in the esophagus. Thus, food that passes by them may get held up temporarily. The gastroenterologist that performs the banding will usually inform the patient about the possibility of this occurring. Avoiding solid foods such as meat and chicken for the first couple of days after banding will help avoid this side effect. On the other hand, pain is uncommon after a banding procedure, and
medications for pain are not given routinely.
Lower GI Series
Preparation
Colonoscopy (koh-luh-NAH-skuh-pee) lets the physician look inside your entire large intestine, from the lowest part, the rectum, all the way up through the colon to the lower end of the small intestine. The procedure is used to look for early signs of cancer in the colon and rectum. It is also used to diagnose the causes of unexplained changes in bowel habits. Colonoscopy enables the physician to see inflamed tissue, abnormal growths, ulcers, and bleeding. For the procedure, you will lie on your left side on the examining table. You will probably be given pain medication and a mild sedative to keep you comfortable and to help you relax during the exam. The physician will insert a long, flexible, lighted tube into your rectum and slowly guide it into your colon. The tube is called a colonoscope (koh-LON-oh-skope). The scope transmits an image of the inside of the colon, so the physician can carefully examine the lining of the colon. The scope bends, so the physician can move it around the curves of your colon. You may be asked to change position occasionally to help the physician move the scope. The scope also blows air into your colon, which inflates the colon and helps the physician see better. If anything abnormal is seen in your colon, like a polyp or inflamed tissue, the physician can remove all or part of it using tiny instruments passed through the scope. That tissue (biopsy) is then sent to a lab for testing. If there is bleeding in the colon, the physician can pass a laser, heater probe, or electrical probe, or inject special medicines through the scope and use it to stop the bleeding. Bleeding and puncture of the colon are possible complications of colonoscopy. However, such complications are uncommon. Colonoscopy takes 30 to 60 minutes. The sedative and pain medicine should keep you from feeling much discomfort during the exam. You will need to remain at the endoscopy facility for 1 to 2 hours until the sedative wears off.
PreparationYour colon must be completely empty for the colonoscopy to be thorough and safe. To prepare for the procedure you may have to follow a liquid diet for 1 to 3 days beforehand. A liquid diet means fat-free bouillon or broth, strained fruit juice, water, plain coffee, plain tea, or diet soda. Gelatin or popsicles in any color but red may also be eaten. You will also take one of several types of laxatives the night before the procedure. Also, you must arrange for someone to take you home afterward--you will not be allowed to drive because of the sedatives. Your physician may give you other special instructions. Inform your physician of any medical conditions or medications that you take before the colonscopy.
Upper GI Series
Preparation
|
|
|||||||
|
|||||||
|
|
|||||||
|
|
|||||||







